Kestra Medical Technology Services, Inc.
$515.4K 13,441 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Painteq LLC
Painteq LLC reported $515,983.50 across General Payments, Research, and Ownership to 4,787 physicians and teaching hospitals across 4,792 transactions.
- $516.0K Above-median payer
- All-tracks total
- 4,792 Top quartile volume
- Transactions
- 4,787 Top quartile reach
- Recipients
- −$159.1K
- General Payments vs PY2023
Painteq LLC reported $515,983.50 across all CMS Open Payments tracks (General + Research + Ownership) to 4,787 physicians and teaching hospitals in Program Year 2024 - ranking #752 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $367,796.50, averaging $107.79 per recipient.
How Painteq LLC's $516.0K all-tracks total breaks down
Painteq LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
36/100
Total payments
F
15/100
Transaction volume
F
45/100
Physician reach
F
46/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer painteq-llc Painteq LLC
$516.0K · #752/1,925 · 0.0% industry · PY2024
- TOT $516.0K
- RANK #752
- SHARE 0.0%
- TXN 4,792
- RCP 4,787
- CAT 3
- GEN $367.8K
- ΔGEN −$159.1K
- TOP1 8.5%
- PY 2024
Volume peers
Nearest volume peer: Kestra Medical Technology Services, Inc. ($515.4K)
Painteq LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Painteq LLC's CMS-reported General Payments decreased by $159.1K (−30.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: PAINTEQ LLCPY2023: PAINTEQ LLCPY2024: PAINTEQ LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $526,943.62
- PY2024
- $367,796.50
What the Data Shows for Painteq LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Painteq LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 3 general-payment categories charted below, "Food and Beverage" is the largest at $204.5K across 4,732 transactions, 55.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Painteq LLC's 3-category general-payment breakdown at $204.5K, 55.6% of the reported total.
How Painteq LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $204.5K | 4,732 | 55.6% |
| Education | $98.3K | 39 | 26.7% |
| Consulting Fee | $65.0K | 16 | 17.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $95,183.82 (25.9%) of $367,796.50 in this company's General Payments records across 1,736 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Painteq LLC
The five named recipients with the highest reported General Payments from this company
- 1
Christopher Bovinet
$31,164.28 across 27 reported transactions
- 2
Dawood Sayed
$21,491.55 across 20 reported transactions
- 3
Jeffrey Henn
$17,345.85 across 15 reported transactions
- 4
Nomen Azeem
$15,435.99 across 47 reported transactions
- 5
Ryan Budwany
$9,746.15 across 11 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Painteq LLC ranks #752 of 1,925 by total payments (top 39% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,556 of 1,838 by HHI (bottom 15% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Darby Dental Supply, LLC : $229.5K total payments, HHI 207
- Incyte Corporation : $13.1M total payments, HHI 206
- Mitsubishi Tanabe Pharma America, Inc. : $415.3K total payments, HHI 205
- Ferring Pharmaceuticals Inc. : $2.0M total payments, HHI 202
- Argentum Medical : $3.5K total payments, HHI 201
- Mission Medical Distribution, LLC : $32.7K total payments, HHI 201
- Painteq LLC (this company) : $367.8K total payments, HHI 201
- SPR Therapeutics, Inc : $1.1M total payments, HHI 200
- Envista Holdings Corporation : $6.0M total payments, HHI 200
- Vericel Corporation : $1.3M total payments, HHI 200
- Straumann USA LLC : $7.6M total payments, HHI 200
- Eclipse Technology Solutions Inc. : $47.7K total payments, HHI 199
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Painteq LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Painteq LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Painteq LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Genetesis, Inc.
$515.3K 13 recipients
Compare payment profiles
Steris Corporation
$514.3K 783 recipients
Compare payment profiles
Novartis Pharma AG
$513.5K 73 recipients
Compare payment profiles
Thea Pharma Inc.
$512.0K 3,562 recipients
Compare payment profiles
Genesis Software Innovations, LLC
$520.5K 8 recipients
Compare payment profiles
Put this to use
Painteq LLC ranks #752 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Painteq LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.